How India’s Biodiversity is Fueling Global Innovation in Biological Ag Inputs

AgriThority’s Luke Samuel details what mistakes biological companies do when taking a product to market.

Without biologicals, the goals of the NAP — and the future of IPM — cannot be achieved, warns WBF Chair and Founder Dr. Minshad Ansari.

Renaissance BioScience Co-CEO John Husnik shares insight on the company’s yeast-based RNA-interference biopesticide technology.

At the core of this agreement is a novel biocontrol product, based on the proprietary strain B2017 of Pseudomonas alloputida.

Executives share insight into whether the tremendous market growth in LATAM is scalable for the biologicals industry.

Learn how China’s shift toward biological solutions is reshaping the crop protection industry and creating new opportunities for growth.

From educating growers, to successful commercialization, bringing biosolutions to market requires a strategic approach, says Certis Biologicals’ Gregory Rogers.

Biological executives share whether they have felt any impact from the regulatory slowdown stemming from the U.S. Endangered Species Act.

Through this collaboration, Corteva will have exclusive distribution rights for Simbiose’s phosphorus solubilizer in more than 20 European countries.